These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10652595

  • 1. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 1999; 19(4B):3073-6. PubMed ID: 10652595
    [Abstract] [Full Text] [Related]

  • 2. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 4. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 5. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 6. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Dec; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 7. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 10. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ, Rahman MA, Isenberg DA, Latchman DS.
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [Abstract] [Full Text] [Related]

  • 11. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT.
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
    Tang JP, Gu YY, Shen N, Ye S, Qian J, Hua J, Chen XG, Chen SL, Bao CD, Wang Y, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2004 Jul 17; 84(14):1157-60. PubMed ID: 15387975
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A, Klimiuk PA, Ciolkiewicz M, Sierakowski S.
    J Rheumatol; 2008 Jul 17; 35(7):1307-13. PubMed ID: 18484695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Jul 17; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.